Phaarmasia Limited (BOM:523620)

India flag India · Delayed Price · Currency is INR
93.49
-4.91 (-4.99%)
At close: Apr 29, 2026
188.91%
Market Cap 671.77M
Revenue (ttm) 449.06M
Net Income (ttm) 177.54M
Shares Out 6.83M
EPS (ttm) 25.99
PE Ratio 3.79
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,952
Average Volume 412
Open 95.40
Previous Close 98.40
Day's Range 93.48 - 95.40
52-Week Range 26.00 - 131.75
Beta 0.92
RSI 52.06
Earnings Date May 26, 2026

About Phaarmasia

Phaarmasia Limited manufactures and sells oral contraceptive pills and iron tablets in India. It offers hormone products, including mifepristone and misoprostaol, desogestrel and ethinyl estradiol, estradiol valerate, levonorgestrel and ethinyl estradiol, medroxyprogesterone acetate, cabergoline, clomiphene citrate, levonorgestrel, progesterone, fluoxymesterone, liothyronine sodium, chlorodehydromethyltestosterone, liothyronine sodium, oxandrolone tablets, testosterone cypionate, methenolone enanthate, drostanolone, testosterone, trenbolone, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 36
Stock Exchange Bombay Stock Exchange
Ticker Symbol 523620
Full Company Profile

Financial Performance

In fiscal year 2025, Phaarmasia's revenue was 243.69 million, a decrease of -20.35% compared to the previous year's 305.93 million. Losses were -15.89 million, 206.7% more than in 2024.

Financial Statements

News

There is no news available yet.